1.44 USD
+0.05 (+3.6%)
1.42 USD
-0.02 (-1.39%)
ChartMill assigns a Buy % Consensus number of 85% to ELDN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.33. This target is 478.47% above the current price.
ELDN was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELDN.
In the previous month the buy percentage consensus was at a similar level.
ELDN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-25 | Craig-Hallum | Initiate | Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-27 | Noble Capital Markets | Initiate | Outperform |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-06-01 | SVB Leerink | Maintains | Outperform |
| 2021-11-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-27 | SVB Leerink | Maintains | Outperform |
| 2021-03-23 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-02-08 | SVB Leerink | Initiate | Outperform |
ELEDON PHARMACEUTICALS INC / ELDN FAQ
Can you provide the average price target for ELEDON PHARMACEUTICALS INC stock?
13 analysts have analysed ELDN and the average price target is 8.33 USD. This implies a price increase of 478.47% is expected in the next year compared to the current price of 1.44.
What is the consensus rating for ELEDON PHARMACEUTICALS INC (ELDN) stock?
The consensus rating for ELEDON PHARMACEUTICALS INC (ELDN) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.